Alto Neuroscience, Inc. (ANRO) Free cash flow 2023–2025
Alto Neuroscience, Inc. (ANRO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$51.8MFY2025 · since FY2023: -$33.9M → -$51.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.8M | -4.6% |
| FY2024 | -$49.5M | -45.9% |
| FY2023 | -$33.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice